ADMA Biologics, Inc. (ADMA)
9.385
+0.04
(+0.48%)
USD |
NASDAQ |
Aug 31, 16:00
9.385
0.00 (0.00%)
After-Hours: 19:43
ADMA Biologics Cash and Short Term Investments (Quarterly) : 136.02M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 136.02M |
| March 31, 2026 | 138.15M |
| December 31, 2025 | 87.63M |
| September 30, 2025 | 61.38M |
| June 30, 2025 | 90.28M |
| March 31, 2025 | 71.62M |
| December 31, 2024 | 103.15M |
| September 30, 2024 | 86.71M |
| June 30, 2024 | 88.24M |
| March 31, 2024 | 45.32M |
| December 31, 2023 | 51.35M |
| September 30, 2023 | 74.16M |
| June 30, 2023 | 62.51M |
| March 31, 2023 | 69.20M |
| December 31, 2022 | 86.52M |
| September 30, 2022 | 34.91M |
| June 30, 2022 | 52.42M |
| March 31, 2022 | 69.50M |
| December 31, 2021 | 51.09M |
| September 30, 2021 | 34.41M |
| June 30, 2021 | 42.41M |
| March 31, 2021 | 61.97M |
| December 31, 2020 | 55.92M |
| September 30, 2020 | 59.68M |
| June 30, 2020 | 75.78M |
| Date | Value |
|---|---|
| March 31, 2020 | 101.24M |
| December 31, 2019 | 26.75M |
| September 30, 2019 | 48.01M |
| June 30, 2019 | 73.62M |
| March 31, 2019 | 16.53M |
| December 31, 2018 | 22.75M |
| September 30, 2018 | 42.37M |
| June 30, 2018 | 55.15M |
| March 31, 2018 | 27.62M |
| December 31, 2017 | 44.61M |
| September 30, 2017 | 13.60M |
| June 30, 2017 | 25.57M |
| March 31, 2017 | 8.788M |
| December 31, 2016 | 15.31M |
| September 30, 2016 | 18.93M |
| June 30, 2016 | 23.82M |
| March 31, 2016 | 11.62M |
| December 31, 2015 | 16.81M |
| September 30, 2015 | 20.94M |
| June 30, 2015 | 23.75M |
| March 31, 2015 | 28.08M |
| December 31, 2014 | 21.85M |
| September 30, 2014 | 20.27M |
| June 30, 2014 | 24.18M |
| March 31, 2014 | 28.72M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Erasca, Inc. | 268.74M |
| Krystal Biotech, Inc. | 845.63M |
| Vericel Corp. | 162.46M |
| Emergent BioSolutions, Inc. | 140.90M |
| Exelixis, Inc. | 839.38M |